Drug and pharmaceutical recalls
17658 federal recalls on file. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2026-05-21FDA-PRJXK Enterprises, IncBoner Bears Chocolate recalled for undeclared sildenafil
JXK Enterprises, Inc is voluntarily recalling Boner Bears Chocolate, Lot #BB21125, after being notified that FDA laboratory analysis confirmed the presence of sildenafil, an active ingredient in the FDA-approved prescription drug Viagra, which is not declared on the product label.
- 2026-05-20FDA-DrugAscend Laboratories, LLCClass IIAscend Laboratories metoprolol recalled for dissolution failure
Failed Dissolution Specifications
- 2026-05-20FDA-DrugENDO USA, Inc.Class IIEndo USA buprenorphine injection recalled for particulate matter
Presence of particulate matter: identified as Buprenorphine free base
- 2026-05-20FDA-DrugOasis Medical, Inc.Class IIOasis Tears PF eye drops recalled for sterility assurance issue
Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision.
- 2026-05-13FDA-PRSun Pharma doxorubicin injection recalled for glass particles
FOR IMMEDIATE RELEASE MUMBAI, INDIA and PRINCETON, NJ - May 13, 2026 – Sun Pharma is voluntarily recalling within the U.S. to the hospital/user level, one batch of DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL, Lot # HAG2581B, Expiration 05/2027 (675 vials). The single batch of 675 vials i
- 2026-05-08FDA-PRPharmacalMG217 eczema cream recalled for bacterial contamination
- May/8/2026- Jackson, WI, Pharmacal is recalling one lot of MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube to the consumer level. The product has been found to be contaminated with Staphylococcus aureus.
- 2026-04-29FDA-DrugTeva Pharmaceuticals USA, IncNot Yet ClassifiedReturn Teva Claravis isotretinoin to your pharmacy
Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
- 2026-04-28FDA-PRB. Braun Medical, Inc.Stop using B. Braun Lactated Ringer's Injection
For Immediate Release - BETHLEHEM, PA – APRIL 28, 2026 – B. Braun Medical Inc. is voluntarily recalling two lots of Lactated Ringer’s Injection, E7500, 1L, to the hospital/healthcare facility level. The product has been found to have particulate matter in solution.
- 2026-04-22FDA-DrugAvantor Performance Materials LLCClass IIIStop using Avantor Magnesium Chloride
Subpotent drug
- 2026-04-22FDA-DrugIsland Kinetics, Inc. d.b.a. CoValence LaboratoriesClass IIStop using Skin Script Blemish Spot Treatment
Failed Stability Specifications
- 2026-04-22FDA-DrugThe Harvard Drug Group LLCClass IIStop using recalled memantine hydrochloride capsules
Failed Dissolution Specifications
- 2026-04-22FDA-DrugInternational Medication Systems Ltd.Class IIStop using recalled epinephrine injection
Lack of Assurance of Sterility
- 2026-04-22FDA-DrugIsland Kinetics, Inc. d.b.a. CoValence LaboratoriesClass IIIStop using Island Kinetics Essential Calming Skin Gel
Subpotent Drug
- 2026-04-22FDA-DrugIsland Kinetics, Inc. d.b.a. CoValence LaboratoriesClass IIIStop using Island Kinetics Hydrocortisone Balm
Subpotent Drug
- 2026-04-22FDA-DrugIsland Kinetics, Inc. d.b.a. CoValence LaboratoriesClass IIIStop using Remedy Gel hydrocortisone
Subpotent Drug
- 2026-04-22FDA-DrugNephron SC, LLCClass IIStop using Nephron SC albuterol solution
Labelling: Illegible label
- 2026-04-22FDA-DrugSUN PHARMACEUTICAL INDUSTRIES INCClass IIStop using Taro fluocinonide cream
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
- 2026-04-22FDA-DrugSUN PHARMACEUTICAL INDUSTRIES INCClass IIStop using Taro Fluocinonide Cream, Lot AD76251
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
- 2026-04-22FDA-DrugSUN PHARMACEUTICAL INDUSTRIES INCClass IIStop using Taro fluocinonide cream
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
- 2026-04-22FDA-DrugPAYLESS COMPOUNDERS, LLCClass IIStop using Payless Compounders semaglutide injections
Lack of Assurance of Sterility
- 2026-04-22FDA-DrugXiamen Kang Zhongyuan Biotechnology Co., Ltd.Class IIStop using QC Quality Choice cough drops
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- 2026-04-22FDA-DrugXiamen Kang Zhongyuan Biotechnology Co., Ltd.Class IIStop using QC Quality Choice cough drops
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- 2026-04-22FDA-DrugXiamen Kang Zhongyuan Biotechnology Co., Ltd.Class IIStop using QC Quality Choice cough drops
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- 2026-04-22FDA-DrugXiamen Kang Zhongyuan Biotechnology Co., Ltd.Class IIStop using QC Quality Choice throat drops
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- 2026-04-22FDA-DrugXiamen Kang Zhongyuan Biotechnology Co., Ltd.Class IIStop using QC Quality Choice cough drops
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- 2026-04-22FDA-DrugXiamen Kang Zhongyuan Biotechnology Co., Ltd.Class IIStop using QC Quality Choice cough drops
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- 2026-04-22FDA-DrugXiamen Kang Zhongyuan Biotechnology Co., Ltd.Class IIStop using QC Quality Choice cough drops
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- 2026-04-22FDA-DrugXiamen Kang Zhongyuan Biotechnology Co., Ltd.Class IIStop using MGC Health Menthol Cough Drops
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- 2026-04-22FDA-DrugXiamen Kang Zhongyuan Biotechnology Co., Ltd.Class IIStop using MGC Health cough drops
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- 2026-04-22FDA-DrugXiamen Kang Zhongyuan Biotechnology Co., Ltd.Class IIStop using MGC Health cough drops
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief